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  I 
Abstract 
A large number of animal models have been established, which mimic the development of the 
human brain or the conditions of human CNS disorders. However, the use of laboratory 
animals is time consuming, expensive and creates ethical concerns. Thus, replacement of 
these models with relevant human in vitro systems appears attractive. In this study the well 
characterized human NT2 teratocarcinoma (NTera-2) cell line was used as in vitro model in 
two different assays to investigate potential neuroprotective and potential neurotoxic 
compounds. Postmitotic NT2 neurons were generated by rapid differentiation in sphere 
cultures as described by Paquet-Durand et al. (2003). 
To analyze the efficacy of potential neuroprotective compounds, cell physiological 
experiments were performed with postmitotic neurons. In simulated ischaemic conditions in 
cultures of purified NT2 neurons the application of low doses of the antihypertensive drug 
and calcium channel blocker diltiazem protected against excitotoxic neuronal damage in vitro. 
Experiments with primary cortical mouse neuron cultures demonstrated a similar response to 
simulated ischaemia and confirmed the neuroprotective effect of diltiazem. 
In a second approach potential developmental neurotoxic compounds [lead-acetate, methyl 
mercury, valproic acid (VPA), methylazoxy methanol acetate (MAM)] and non 
developmental neurotoxic compounds [paracetamol and glutamate] were analyzed in 
migration assays using differentiating human NT2 neurospheres. Neurospheres were formed 
under non-adherent conditions and cell migration was assayed by placing spheres onto an 
adherent substrate in the presence of test compounds. Cell migration out of these 
neurospheres was determined microscopically and compared to acute toxicity. The 
developmental neurotoxins inhibited specifically migration, whereas EC50 values for non 
developmental neurotoxins did not differ as expected from acute toxicity values. 
In summary, these results demonstrate that cell cultures of human model neurons can provide 
an important initial test system for drug development in stroke therapy. Furthermore, they 
show that it is possible to perform in vitro tests for developmental neurotoxicity which are 
predictive for the effects of known developmental neurotoxins. Thus, the NT2 cell line offers 
a promising perspective towards establishing in vitro assays as replacement for drug and toxin 
screening in vivo. 
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Zusammenfassung 
Es wurde eine Vielzahl an Tiermodellen entwickelt, die die Entwicklung des menschlichen 
Gehirns oder die Bedingungen von Erkrankungen des menschlichen ZNS nachahmen. Jedoch ist 
der Gebrauch der Labortiere Zeit intensiv, teuer und verursacht ethische Bedenken. Darum ist ein 
Austausch dieser Modelle mit relevanten menschlichen in vitro Testsystemen vorteilhaft. In dieser 
Studie wurde die menschliche teratocarcinoma NT2 (NTera-2) Zelllinie als in vitro Modell in 
zwei verschiedenen Testsystemen benutzt, um potentielle neuroprotektive und potentielle 
neurotoxische Substanzen zu analysieren. Postmitotische NT2 Neurone wurden durch eine 
schnelle Differenzierungsmethode, wie von Paquet-Durand et al. (2003) beschrieben, erzeugt. 
Um die Wirksamkeit von möglichen neuroprotektiven Substanzen zu analysieren, wurden 
physiologische Experimente mit postmitotischen NT2 Neuronen durchgeführt. Unter simulierten 
ischämischen Bedingungen in neuronalen NT2 Kulturen konnte gezeigt werden, dass niedrige 
Dosen des Bluthochdruckmittels und Kalziumkanalblockers Diltiazem die Zellen gegen 
exzitotoxische Schädigung schützt. Experimente unter anoxischen und hypoglycämischen 
Bedingungen mit primären kortikalen Mauszellkulturen zeigten einen ähnlichen Effekt und 
bestätigten die neuroprotektive Wirkung von Diltiazem. 
In einem weiteren Ansatz wurden potentielle entwicklungsneurotoxische Substanzen [Bleiazetat, 
Methylquecksilber, Valproinsäure (VPA), Methylazoxymethanolazetat (MAM)] und nicht-
entwicklungneurotoxische Substanzen [Paracetamol und Glutamat] in Migrationsassays mit 
differenzierenden NT2 Neurosphären untersucht. Die Neurosphären wurden unter nicht-
adhärenten Bedingungen gebildet und die Migrationsassays wurden dann unter adhärenten 
Bedingungen in Anwesenheit der Testsubstanzen durchgeführt. Die Zellmigration aus diesen 
Neurosphären heraus wurde mikroskopisch ermittelt und mit den zytotoxischen Eigenschaften der 
Testsubstanzen verglichen. Für die Entwicklungsneurotoxine konnte eine spezifische Hemmung 
der Migration nachgewiesen werden, während die EC50 Werte für die nicht-
entwicklungsneurotoxischen Substanzen sich erwartungsgemäß nicht von der Zytotoxizität 
unterschieden. 
Zusammenfassend zeigen diese Ergebnisse, dass es möglich ist Zellkulturen von humanen NT2 
Neuronen für ein Testsystem zu benutzen, mit dem neuroprotektive Substanzen für die 
Hirnschlagtherapie gefunden werden können. Außerdem besteht die Möglichkeit, in vitro Tests 
für Entwicklungsneurotoxizität durchzuführen, welche die Effekte von bekannten 
Entwicklungsneurotoxinen bestätigen. So bietet die NT2 Zelllinie eine viel versprechende 
Alternative zur Etablierung von in vitro Assays um in vivo Screening Testsysteme zu ersetzen. 
 
Schlagwörter: humane NT2 Neuronen, Neuroprotektion, Entwicklungsneurotoxizität
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Abbreviation    Full name 
MTT 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium 
bromide 
NHNP Normal human neural progenitor 
N.D.     not determinable 
ns     not significant 
NMDA    N-methyl-D-aspartate 
NF     Neurofilament 
NT2     NTera-2 
PBS     Phophate buffered saline 
PDL     Poly-d-lysine 
Pb-ac     Lead-acetate 
PGCs     Primordial germ cells 
PFA     Paraformaldehyde 
PMA     Phorbol 12-myristate 13-acetate 
PKC     protein kinase C 
PCBs     polychlorinated biphenyls 
PTX     PBS with 0.1 % Triton X100 
RA     Retinoic acid 
SEM     Standard error of the mean 
s.p.     synaptic punctae 
SMBS     Sodium metabisulphite 
TH     Tyrosine Hydroxylase 
Urd     1-ß-D-ribofuranosyluracil 
VPA     Valproic acid 
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1. Introduction 
In biomedical assays, the use of original human brain tissues is restricted because of 
availability and ethical concerns. Thus, cell based in vitro models are the most suitable 
alternative. The use of human nerve cells, generated and multiplied on a large scale in culture 
could provide alternative test systems for pharmacological studies as replacement for animal 
models. A relevant human in vitro system could facilitate and simplify drug and toxin 
screening as well as the study of disorders of the central nervous system (CNS) or could serve 
as a source for neural transplantation. 
 
Fig. 1 Origin of human pluripotent stem cells. Embryonic stem (ES) cells are derived from the 
inner cell mass of the pre-implantation embryo, Embryonic germ (EG) cells are derived from 
primordial germ cells (PGCs) isolated from the embryonic gonad and Embryonal carcinoma 
(EC) cells are stem cells of testicular tumours in the adult. Pluriopotent stem cells can be 
induced into neuronal cells by treatment with retinoic acid (RA). Figure modified from 
Donovan and Gearhart (2001) 
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Sources for human neurons are pluripotent stemm cells which have the potential to generate 
any cell type in the body. They could derive from embryonic carcinoma (EC) cells, 
embryonic stem cells (ES) or embryonic germ (EG) cells. EC cells are stem cells of testicular 
tumours in the adult, ES cells are derived from pre-implantation embryos and EG cells are 
derived from primordial germ cells (PGCs) of the post-implantation embryo (Fig. 1). The 
disadvantage for the use of ES or EG cells is the fact that the sources of these cells are human 
embryos, which raise questions of ethical concerns. 
This study is based on the well characterized human NT2 teratocarcinoma (NTera-2) EC cell 
line which can be induced with retinoic acid to differentiate into post-mitotic human neurons. 
Two different assays for neurobiological research were applied:  
Differentiated NT2 neuronal cells were used as a model of the excitotoxic cascade during 
stroke and differentiating human NT2 neurospheres were used in migration assays as in vitro 
test systems for developmental neurotoxicity. 
1.1 The NT2 cell line 
In this study the human teratocarcinoma cell line Ntera-2 (NT2) which has been derived from 
a human testicular cancer (Andrews, 1984) was used to develop human neuronal in vitro 
model systems. NT2 cells can be induced to differentiate into post-mitotic neurons, upon 
exposure to retinoic acid (RA), which is a potent inducer of normal mammalian neural 
development (Lee and Andrews, 1986 / Pleasure et al., 1992). In culture, NT2 neuronal cells 
show neuronal morphology, migrate to form ganglion-like cell conglomerates and are 
immunoreactive to neuronal cytoskeletal markers such as MAP2, Tau, and NF-66 (Pleasure et 
al., 1992). These NT2 neuronal cells display a variety of neurotransmitter phenotypes 
(Guillemain et al., 2000) and have been used in a large number of biomedical investigations in 
the past 2 decades (reviewed by Paquet-Durand and Bicker, 2007). The neuronal 
differentiation of NT2 cells leads to increased expression levels of synapsins (Leypoldt et al., 
2002) and under specific culture conditions, these neurons form functional synapses (Hartley 
et al., 1999). NT2 cell line can be used as a model for hypoxic-ischaemic cell injury (Munir et 
al., 1995) and they have been used to study the effects of anoxia and hypoglycaemia in vitro 
(Rootwelt et al., 1998). This cell type has also been used in several transplantation studies, 
which have demonstrated successful engraftment in experimental animals (Trojanowski et al., 
1993) and human stroke patients (Nelson et al., 2002). In this context, the induction of a 
dopaminergic phenotype seemed interesting for transplantation studies of dopamine lesions, 
for instance caused by Parkinson disease. It has been reported that NT2 neurons can be 
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differentiated into a dopaminergic phenotype under exposure to lithium (Zigova et al., 1999; 
2000), or a mix of growth factors, dopamine, and high intracellular cAMP levels by 
application of forskolin and IBMX (Iacovitti et al., 2001). 
Moreover, NT2 neurons would allow for high throughput screening of chemical compounds 
both for possible therapeutical use and for risk assessment of developmental neurotoxins (Hill 
et al., 2008). 
One disadvantage of the NT2 system has been the time-consuming process (up to two 
months) needed to generate purified postmitotic neurons. In this study a new method utilizing 
freely flowing aggregates, which significantly shorten the differentiation process up to one 
month (Paquet-Durand et al., 2003) was applied. This method is based on the observation that 
a high concentration of RA, together with the influence of cell-cell adhesion in neurosphere 
aggregates facilitates neurogenesis in comparison to the classical differentiation in surface 
attached monolayer culture (Pleasure et al., 1992). 
1.2 Simulation of ischaemia 
Ischaemic brain injury is a major cause of death and health problems in industrialized 
countries with a demographic shift towards an ageing population. Brain damage following 
acute ischemic stroke results from the obstruction of blood supply to nerve cells, setting off 
membrane depolarization, which causes the release of the excitatory neurotransmitter 
glutamate. The excessive extracellular accumulation of glutamate stimulates glutamate 
receptors of surrounding cells, inducing increases in intracellular Ca2+ levels and the 
production of free radicals, which orchestrate cell injury via the so-called excitotoxic cascade 
(Olney, 1974; Choi, 1985; Coyle and Puttfarcken, 1993; Kristián and Siesjö, 1998; Nichols 
and Ward, 2000). In addition, a chain reaction triggered by glutamate leakage from the dying 
brain cells endangers neurons in the penumbra, a much larger region surrounding the core 
infarct. Because cell death and the expansion of the penumbra occur over a period of hours to 
days, there are therapeutic windows for intervening at critical steps of the excitotoxic cascade. 
One approach of reducing the delayed death of brain cells following stroke (Dirnagl et al., 
1999; Lee et al., 1999) involves the application of neuroprotective substances such as 
glutamate receptor blockers, free radical scavengers and inhibitors of cell death signalling 
pathways. However, despite much animal research into the cellular mechanisms of ischaemic 
brain injury, so far little of this work has translated into clinical treatments for stroke in 
human patients (Hoyte et al., 2004b). In vitro models are often used to investigate 
pathophysiological mechanisms of brain cell injury and to develop therapeutic approaches 
  4 
(Melzian et al., 1999; Campbell et al., 2000; Melena and Osborne, 2001). In this study 
neurons generated by rapid differentiation in sphere cultures from the human teratocarcinoma 
cell line NT2 were used to investigate the excitotoxic cascade. These neurons integrate and 
survive in rodent brains (Kleppner et al., 1995) and promote functional recovery in a rat 
model of transient focal ischaemia (Borlongan et al., 2000). In a transplantation study for 
treating stroke in human patients, the therapeutic application of NT2 neurons has also been 
successfully demonstrated (Kondziolka et al., 2001). NT2 neurons respond to glutamatergic 
stimulation with increases in cytosolic Ca2+ levels. They express functional N-methyl-D-
aspartate (NMDA) receptors, ionotropic glutamate receptor channels that are permeable to 
Ca2+ and Na+. NT2 Neurons are vulnerable to combined anoxia/hypoglycemia, an effect 
which is exacerbated by the addition of glutamate (Paquet-Durand and Bicker, 2004). 
In this study the protective effect against ischaemic damage of diltiazem, a licensed drug that 
is commonly used to treat heart arrhythmias, high blood pressure and angina pectoris 
(reviewed in Chaffman and Brogden, 1985), has been examined with human model neurons in 
vitro. To compare this model with an animal model the response to simulated ischaemia in 
primary cortical mouse neuron cultures has also been analysed. 
1.3 Neuronal Migration 
Besides differentiation and synaptogenesis, cell migration is an essential process during 
development of the central nervous system (CNS). Within the developing nervous system, 
cells migrate several centimeters before reaching their proper positions and forming the 
correct connections. Two different types of migration are known: radial migration, which 
describes the migration of neurons along glial fibers; and tangential migration, in which cells 
migrate orthogonal to the direction of radial migration, increasing cellular complexity and 
connectivity (Marin and Rubenstein, 2003). Defects in neuronal migration lead to several 
functional pathologies like autism, attention deficit disorder, mental retardation and cerebral 
palsy (Grandjean and Landrigan, 2006) or like lissencephaly and heterotopia (Pilz et al., 
2002). Exposure to developmental neurotoxic compounds could lead to migration disorders as 
seen in the fetal alcohol syndrome (Miller, 1993 / Guerri, 1998) or mercury intoxication 
(Clarkson, 2002). Only few industrial chemicals (lead, methylmercury, polychlorinated 
biphenyls [PCBs], arsenic and toluene) are proven to cause human brain injury by exposure to 
these chemicals during early fetal development (Grandjean and Landrigan, 2006). The 
developing human brain is much more susceptible to injury and doses needed to affect are 
much lower than those affecting adult brain function. For that reason, the recognition of 
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developmental neurotoxicity in children exposed to industrial chemicals often ocured after 
recognition of neurotoxicity at high doses in the adult nervous system (Fig. 2). Exposure on 
childhood populations at low doses lead to subclinical toxicity and a pandemic of subclinical 
neurotoxicity is therefore supposable to be silent. Due to the fact that the documentation of 
most neurotoxicants is directed toward adults only, there is a great need to generate new 
approaches which are able to give clear evidences about the potential of chemicals to disturb 
human brain development. 
 
Fig. 2 The effects of a neurotoxic chemical on a population over time. For identification of 
chemicals toxic to neurodevelopment, the first evidence dealt with adverse effects of high 
doses on the adult nervous system, and was followed by case reports and epidemiological 
evidence on developmental toxicity at successively lower doses, to which childhood 
populations of increasing magnitude were exposed. Figure from Grandjean and Landrigan 
(2006) 
 
For identifying potential developmental neurotoxic chemicals and discovering the mechanism 
that control neuronal migration, many different animal in vivo and in vitro assays have been 
used, like live cell imaging of granule mouse neurons (Fishman and Hatten, 1993), the 
technique of photographing murine cerebellar cells on a CELLocate grid coverslip (Sass et al., 
2001) or microscopical observation of organotypic insect midgut cultures (Haase and Bicker, 
2003). To study human neuronal migration Moors et al. (2007) established a human 
neurosphere-based migration assay using normal human neural progenitor (NHNP) cells, in 
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which the distance is measured that cells wander over time. Hill et al. (2008) examined with 
human NT2 cells endpoints of cell viability and neuronal protein marker expression, to 
identify developmental neurotoxins. Tegenge and Bicker (2009) showed that aggregates of 
human NT2 precursor cells are a useful tool to study regulatory mechanism of cell motility. 
According to these methods a migration assay for developmental neurotoxicity with 
differentiating human NT2 neurospheres seemed interesting. When one-week retinoic acid 
treated NT2 neurospheres were seeded on an adherent surface, cells started to migrate out of 
these spheres. The distances the cells transfer over time could be measured with and without 
the present of test substances to analyse potential developmental neurotoxic effects. With 
exposure to model substances like Ethanol, which inhibits migration, or Phorbol-12-
myristate-13-acetate (PMA), which stimulates migration of neuronal cells (Sears and Ciment, 
1988), a migration assay could be developed, which allows testing several potential 
developmental neurotoxic compounds. 
 
1.4 Aim of this study 
The intention of this study was to establish the human NT2 cell line as human neuronal in 
vitro model systems for replacement of animal models. Firstly, the terminally differentiated, 
postmitotic NT2 neurons generated by rapid differentiation in sphere cultures (Paquet-Durand 
et al., 2003) have been characterised using immunocytochemical methods. The expression of 
a particular neurotransmitter phenotype seemed to be interesting for transplantation studies. 
Examples would be the induction of a dopaminergic phenotype for transplantation studies of 
dopamine lesions caused by Parkinson disease or the cholinergic phenotype for replacement 
of degenerating motorneurons. 
In cell physiological experiments with simulated ischaemic conditions in cultures of purified 
NT2 neurons the efficacy of potential neuroprotective compounds could be analysed in vitro 
(Paquet-Durand and Bicker, 2004). The protective effect against ischaemic damage of 
diltiazem should be examined and compared with the response to simulated ischaemia in 
primary cortical mouse neuron cultures. 
Furthermore, a migration assay with differentiating human NT2 neurospheres should be 
established to analyse potential developmental neurotoxic compounds. Cell migration out of 
these neurospheres could be determined microscopically and compared to acute cytotoxicity 
measured with an Alamar Blue® viability assay. 
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2. Materials and Methods 
2.1 NT2 cell culture and differentiation 
The human Ntera2/D1 cell line (NT2) was obtained from ATCC (American Type Culture 
Collection, VA, USA). NT2 precursor cells were maintained and cultivated in DMEM/F12 
culture medium (Gibco-Invitrogen, Karlsruhe/Germany) supplemented with 10% fetal bovine 
serum (FBS, Gibco-Invitrogen) and 1% penicillin/streptomycin (Gibco-Invitrogen) in the 
atmosphere of 5% CO2 at 37°C (Andrews 1984). Generation of NT2 neurons was performed 
using the differentiation protocol in free-floating aggregates by Paquet-Durand et al. (2003). 
Briefly, the NT2 precursor cells were seeded in 80 mm, bacteriological grade Petri dishes 
(Greiner, Hamburg/Germany) at a density of 4×106–5×106 cells per dish. On the first day, 10 ml 
of cell culture medium was added to each Petri dish. On the second day and later on, retinoic acid 
(RA) was added to the medium to yield a final concentration of 10 µM. Every 2–3 days the 
medium was changed by transferring the cell suspension to centrifuge tubes. Remaining cell 
conglomerates were washed off with a few milliliters of medium. Cells were centrifuged at 
200×g for 5 min, resuspended in 10 ml of medium containing 10 µM RA, and seeded on new 
Petri dishes. After 7–8 days the cell conglomerates from one Petri dish were seeded in T75 cell 
culture flasks (Falcon, Franklin Lakes, NJ, USA) and cultured for another 6– 8 days. Cells were 
trypsinized (Trypsin-EDTA (1X), Gibco- Invitrogen), transferred to T175 cell culture flasks and 
cultured in T175 flasks for 2 days to obtain conditioned medium. Then the cells were trypsinized, 
transferred to T75 flasks and supplied with inhibitor medium (1-6- D-arabinofuransylcytosine: 1 
µM, 2′-deoxy-5-fluorouridine: 10 µM, 1-β-D-ribofuranosyluracil: 10 µM). After 7–10 days, 
neurons were completely differentiated and growing on a layer of non-neuronal cells. For that 
reason neurons were selectively trypsinized. After differentiation, NT2 neurons were plated on 
poly-D-lysine (PDL) and matrigel (Becton-Dickinson, Bedford, MA, USA / see 2.2) coated 96-
well plates (Falcon) or cover glasses at a density of 10,000-50,000 cells per well and cultured for 
1-5 weeks. To limit evaporation from outer wells in long-term cultures, cells were not seeded in 
the outermost wells. The concentric ring of empty wells around the neuronal cell cultures was 
filled with sterile phosphate buffered saline (PBS). Cell cultures were maintained in a humidified 
incubator at 37 °C and 5% CO2. 
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To store undifferentiated precursor cells or neurons whenever needed, they were transferred to 
ice-cold 95% FBS / 5% DMSO medium and frozen in liquid nitrogen. 
In order to induce a dopaminergic phenotype, differentiated NT2 neurons were incubated for up 
to one week with 1 mM lithium chloride and a mixture of fibroblast growth factor 1 (FGF1, 1 
ng/ml), 12-O-Tetradecanoylphorbol 13-acetate (TPA, 200 nM), dopamine (20 µM], 3-isobutyl-1-
methylxanthine (IBMX, 250 µM) und forskolin (50 µM). ). As a positive control for dopamine 
immunostaining the cells were preincubated for 15 min in 1 mM dopamine prior to fixation. For 
the detection of cell proliferation, cells were incubated with 50 µM BrdU (5-bromo-2’-
deoxyuridine) for 2 h prior to fixation. 
2.2 Coating of cell culture ware 
Plastic and glass ware was coated with PDL and matrigel before neuronal cells were plated. A 
stock solution containing 1 mg/ml poly-d-lysine in sterile distilled water was diluted 1:100 (final 
concentration: 10 µg/ml) and the surface to be coated was incubated with this solution for 2h. 
After incubation the liquid was removed and allowed to dry completely at room temperature. A 
matrigel coating followed this. A matrigel matrix solution (approx. 10 mg/ml) was diluted 1:30 in 
ice cold DMEM/F12 and was pipetted up and down with a fire polished Pasteur pipet 5-10 times 
to ensure even distribution of matrigel. To each well of a 96 well plate approx. 100 µl of this 
solution were added and incubated for 2 h. Afterwards the liquid was removed and the plates 
dried completely at room temperature. Larger surfaces (such as glass cover slips) were incubated 
with a volume of matrigel solution large enough to cover the entire surface. 
2.3 Mouse and human brain tissue 
Mouse brain tissue (a kind gift from the Institute of Physiology, University of Veterinary 
Medicine, Hannover) was used as a positive control for tyrosine hydroxylase immunostaining. 
Mouse brains were fixed in PBS containing 4 % paraformaldehyde (PFA) and placed in PBS with 
30 % sucrose. After freezing the tissue in liquid nitrogen, the brain was sectioned at 20 µm on a 
Reichert-Jung Frigocut 2800E cryostat microtome at -20°C and collected on PDL coated slides. 
As a second positive control for tyrosine hydroxylase immunostaining a human brain tissue 
section microarray (Oligene, Berlin, Germany, Cat.-No.: 401 1210) was used. 
Immunocytochemical stainings were done as described in 2.4. 
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2.4 Immunocytochemistry 
Cells were washed with PBS once and then fixed for 30 minutes in PBS containing 4 % PFA. For 
the detection of dopamine 1 % glutaraldehyde was added to the fixative. After fixation, cells were 
washed 3 times for 5 minutes in PBS containing 0.1 % Triton X100 (PTX). For the detection of 
dopamine reduction steps with 1 % sodium borohydride and 1 % sodium metabisulphite (SMBS) 
were required. Detection of BrdU required a 20-min incubation in 2 N HCl in PBS after fixation. 
Blocking solution containing PTX and 5 % normal serum from the host animal, from which the 
secondary antibody (Table 1) was obtained, was applied for one hour. Primary antibodies (Table 
1) were diluted in PTX containing 5 % normal serum and applied for one hour. Wells were 
washed 3 times for 5 minutes in PTX and incubated with diluted secondary biotinylated antibody 
(Vector) directed against the host animal of the primary antibody for one hour. After 3 more 
washing steps in PTX immunofluorescence was detected by applying streptavidin bound with 
alexafluor 488 or CY3 for one hour. Finally, cells were incubated for 5-10 minutes in PBS 
containing 10 µM DAPI as a nuclear counterstain and washed 3 times in PBS. For visualisation 
of actin, a solution of phalloidin-Alexa Fluor-568 in PBS was applied for 15 min. 
 
Antibody Provider Dilution 
Monoclonal mouse anti-MAP2 
(clone AP20)  
Sigma, Deisenhofen/Germany 1:500 
Polyclonal rabbit anti-Tau 
(AB1512) 
Chemicon International, Temecula 
(CA)/USA 
1:200 
Monoclonal mouse anti-Tyrosine 
Hydroxylase (MAB318) 
Chemicon International, Temecula 
(CA)/USA 
1:500 
Polyclonal rabbit anti-Tyrosine 
Hydroxylase (AB152) 
Chemicon International, Temecula 
(CA)/USA 
1:200 
Polyclonal rabbit anti-Dopamin 
(AHP847) 
Serotec GmbH, Oxford/UK 1:200 
Polyclonal rabbit anti-GABA 
(A2052) 
Sigma, Deisenhofen/Germany 1:5000 
Polyclonal goat anti-ChAT 
(AB144P) 
Chemicon International, 
Temecula (CA)/USA 
1:100 
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Antibody Provider Dilution 
Monoclonal mouse anti-Synapsin 
(106001, Clone 46.1) 
Synaptic Systems GmbH, 
Göttingen/Deutschland 
1:500 
Monoclonal mouse anti-Nestin 
(MAB5326) 
Chemicon International, Temecula 
(CA)/USA 
1:1000 
Monoclonal mouse anti-Vimentin 
(cloneVS; V6630) 
Chemicon International, Temecula 
(CA)/USA 
1:1000 
Monoclonal mouse anti-
acetylated-α-Tubuline (T6793) 
Sigma, Deisenhofen/Germany 1:1000 
Monoclonal mouse anti-BrdU Sigma, Deisenhofen/Germany 1:200 
Monoclonal mouse anti-β-
Tubuline isotype III 
(cloneSDL.3D10; T8660) 
Sigma, Deisenhofen/Germany 1:10000 
Alexa Fluor 568-Phalloidin      
(200 units/ml)  
Molecular Probes, Eugene 
(OR)/USA 
1:200 
Secondary horse anti-mouse-biotin Vector, Burlingame (CA)/USA 1:250 
Secondary horse anti-rabbit-biotin Vector, Burlingame (CA)/USA 1:250 
Secondary horse anti-goat-biotin Vector, Burlingame (CA)/USA 1:250 
Table 1 List of primary and secondary antibodies used for the immunocytochemical 
characterisations. 
 
2.5 Microscopy, image processing, quantification and statistics 
Morphological observations, routine light microscopy and fluorescence microscopy were 
performed on a Zeiss Axiovert 200 microscope equipped with an HBO 100 Halogen lamp or on a 
Zeiss Axioskop microscope equipped with an HBO 50 Halogen lamp. Images were captured with 
a CoolSNAP EZ camera by using MetaFluor 7.0r1 software rather with an Axio Cam HRc 
camera by using AxioVision 4.7 software. Image overlays and contrast enhancement were done 
using Adobe Photoshop 6.0. 
To quantify fluorescence labeld cells, all cells in one image were counted using the DAPI 
staining and the proportion of positive cells was determined. To quantify synaptic punctae in 
synapsin stainings a mask was generated using the treshold function of ImageJ 4.2 (brightness: 
  11 
+30; contrast: +50; treshold: 0-75) to remove the background staining. The proportion of synaptic 
punctae in relation to the number of cells (DAPI staining) was determined. Statistical 
comparisons among different experimental groups were done using a two-tailed Student's t-test. 
Error bars in the figures indicate the standard error of the mean (SEM), levels of significance are: 
*p<0.05, **p<0.01, ***p<0.001. 
2.6 Anoxia 
NT2 neurons were cultured in 96-well plates for 2–4 weeks prior to the anoxia/hypoglycemia 
experiment. Anoxia experiments were performed in Krebs HEPES buffer (anoxia medium; 1 mM 
NaH2PO4, 118.5 mM NaCl, 5.57 mM KCl, 1.25 mM CaCl2, 1.2 mM MgCl2, 0.03 mM Na2EDTA, 
0.06 mM ascorbic acid, 20 mM HEPES and pH 7.4). The normal cell culture medium was 
replaced by 100 µl anoxia medium immediately before the experiment was started. 2 mM sodium 
dithionite was added to the anoxia medium to scavenge oxygen in the medium. An internal 
positive control (live control) was exposed to anoxia medium without sodium dithionite and these 
wells were closed with airtight caps to maintain normoxic conditions. In samples, the anoxia 
medium was supplemented with 500 µM glutamate and 500 µM glycine. Between 5 and 250 µM 
D-cis-diltiazem was added to these samples. The 96-well plates were placed in a sterile, anoxic 
chamber which was perfused with a mixture of 95 % argon and 5 % CO2 during the full duration 
of the anoxia. The chamber itself was transferred to a 37 °C warm water bath. Temperature inside 
the anoxic chamber was monitored constantly and did not exceed 38 °C. The duration of anoxia 
was measured from the time after the temperature inside the anoxic chamber had reached 37 °C. 
This was usually the case 10–14 min after the chamber was placed into warm water bath. After 2 
h to 3 h 30 min, the anoxia experiment was stopped by reoxygenation and a viability assay was 
assayed several times after the anoxia experiment (see 2.8). 
2.7 Mouse neuronal cell cultures 
Newborn C3H mice from the BMC animal breeding facility were used. All procedures were 
performed in accordance with the Lund University ethics committee (permits #M213-03 and 
#M76-03). Animals were killed by decapitation, the eyes were collected for separate experiments, 
the brains were removed and primary cortical cell cultures were prepared essentially as described 
by Li et al. (1997). Briefly, cortices were placed in a balanced salt solution (BSS; 137 mM NaCl, 
5.3 mM KCl, 0.168 mM Na2HPO4, 0.22 mM KH2PO4, 10 mM HEPES, 33.3 mM Glucose, 43.8 
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mM Sucrose and pH 7.4), cut into small pieces (≈1 mm2) and exposed to BSS containing 10 U/ml 
papain for 30 min at 37 °C. After centrifugation for 5 min at 100×g and resuspension in BSS 
containing 1 % bovine serum albumin (BSA; Boehringer, Mannheim/Germany) and 1 % trypsin 
inhibitor, the pieces were gently dissociated by trituration with a glass micropipette for 20 times 
and with a fire polished glass micropipette for another 10 times. Cells were centrifuged again and 
resuspended in D-MEM/F12 medium (Gibco-Invitrogen) supplemented with FBS and 
penicillin/streptomycine (see 2.1). To enhance the percentage of neuronal cells, the non-neuronal 
cells were allowed to adhere for 30 min to a plastic cell culture dish. The cells in the supernatant 
were then seeded in poly-D-lysine and matrigel matrix (Becton-Dickinson) pre-coated 96-well 
plates with a density of 30,000 cells/well. Proliferation of non-neuronal cells was inhibited by 
adding 1 µM 1-6-D-arabinofuransylcytosine and 10 µM 2′-deoxy-5-fluorouridine (Huettner and 
Baughman, 1986) to the growth medium 1 day after plating. This treatment was continued during 
the next 4 days until anoxia experiments were performed as described above. 
2.8 Cell viability assay 
The development of the viability of cell cultures was monitored using the Alamar Blue® assay. 
In this assay the dye – which is originally blue – is incorporated into the cells, reduced by the 
cells metabolism to a red form, and re-released to the surrounding medium. The viability of a cell 
culture was detected by measuring the absorbance (Fig. 3a) of the liquid medium in a 
photometric microplate reader (Tecan Spectra II) or by measuring the emission (Fig. 3b) of the 
liquid medium in a fluorescence microplate reader (Tecan infinite M200). The photometric 
microplate reader was equipped with 570 nm and 600 nm filters. The fluorescence reader 
measured the fluorescence intensity using an excitation wavelength of 530 nm and an emission 
wavelength of 590 nm and was controlled using i-control 1.3 software. The measured value 
allows to calculate the percentage of the dye that is present in the oxidised and in the reduced 
form. The higher the reduction rate, the higher the viability of the cell culture. 
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Fig. 3 Absorbance- (a) and emission- (b) spektra of the oxidized and reduzed forms of Alamar 
Blue. 
 
For every experiment the viability was measured before and after the treatment of the cells. For 
each measurement the cell culture medium (or Krebs HEPES Buffer) was completely changed 
and replaced with culture medium with 3 % Alamar Blue® solution. The assay volume in 96 well 
plates was 100 µl per well and in 24 well plates 200 µl per well. The plates were read in the 
microplate reader and incubated for 4 h at 37 °C / 5 % CO2 before the plates were read again. 
After the measurement the medium was changed to cell culture medium without Alamar Blue 
and cell cultures were maintained at 37 °C and 5 % CO2 up to the next measurement. 
The viabilities measured before the cells were treated were set to 100 % for each well in every 
sample group. Viabilities measured after treatment, were compared to the values obtained before 
and to the internal positive control. They are given as percentage of the positive control. To 
establish whether a distinctive treatment had a significant effect on viability, the samples were 
compared using Student´s t-test.  
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2.9 Migration assay with NT2 neurospheres 
NT2 neurospheres were formed by one-week treatment of retinoic acid using the first step of the 
differentiation protocol in free-floating aggregates described above (2.1). These neurospheres 
were seeded on PDL and matrigel coated cover glasses (12 mm) in 24 well plates at a density of 
approx. 10 neurospheres in 40 µl medium per well. The neurospheres were allowed to adhere on 
the surface for one hour at 37 °C and 5 % CO2 before adding 500 µl of RA medium to each well 
and incubate for further 48 h. To investigate the effects of several test compounds in different 
experiments the medium was supplemented with a wide spread of concentrations of these 
substances. A positive control was done without additions. The migration was observed under a 
Zeiss Axiovert 200 microscope with 10x objectives. To quantify the cell-migration for every 
sample eight photos, each with one neurosphere, were taken after 24 h and 48 h. The distance 
between the edge of the sphere and the furthest migrated cells were measured using ImageJ 1.41o 
at four distinct position per neurosphere. The cells were fixed after 48h for immunocytochemical 
stainings. For every experiment a viability assay with Alamar Blue after 24 h and 48 h (see 2.8) 
was performed that allowed to compare the migration values with cytotoxicity values. 
Dose/effect-profiles and resultant EC50 values were calculated using Sigma Plot 8.02. 
2.10 Time lapse video microscopy of NT2 neurospheres 
The neurospheres were seeded on 20 mm cover glasses coated with PDL and matrigel and 
incubated for 24 h at 37 °C and 5 % CO2. The cover slip was transferred to an observation 
chamber with culture medium, covered with a 35 mm Petri dish and closed with Parafilm. The 
chamber was maintained at 37 °C. For a time lapse sequence every two minutes a picture was 
taken from a small section of a neurosphere under a Zeiss Axiovert 200 microscope with 10x 
objectives. The migration was observed over night for approx. 24 h and a video was created using 
MetaFluor 7.0r1 software. 
2.11 List of chemical substances, biological agents and cell culture 
material used 
 
Item        Provider 
1-6-D-arabinofuranosylcytosine (Ara C)   Sigma, Taufkirchen/Germany 
1-ß-D-ribofuranosyluracil (Urd)     Sigma, Taufkirchen /Germany 
  15 
Item        Provider 
2'-deoxy-5-fluorouridine (FudR)     Sigma, Taufkirchen /Germany 
Acetaminophen Sigma, Taufkirchen /Germany 
Alamar Blue® Assay  Trek Diagnostic Systems, East 
Grinstead/UK 
Argon/CO2 gas (95%/5%)  Messer Griesheim, Duisburg/Germany 
BrdU (5-bromo-2'-deoxyuridine) Sigma, Taufkirchen /Germany 
BSA (bovines serum albumine) Sigma, Taufkirchen /Germany 
CaCl2         Aldrich, Gillingham/UK 
Cell culture flasks (tissue culture grade)   Falcon, Franklin Lakes (NJ)/USA 
CuSO4        Fluka, Buchs/Switzerland 
CY3 (streptavidin bound)      Vector, Burlingame (CA)/USA 
DAPI        Sigma, Taufkirchen /Germany 
Diltiazem       Sigma, Taufkirchen /Germany 
DMEM/F12 Medium      Gibco, Paisley/UK 
DMSO (dimethyl sulfoxide)      Sigma, Taufkirchen /Germany 
Dopamine hydrochloride     Sigma, Taufkirchen /Germany 
Ethanole       Roth, Karlsruhe/Germany 
Fetal bovine serum (FBS)      Gibco, Paisley/UK 
Fluorescein (streptavidin bound)     Vector, Burlingame (CA)/USA 
FGF-1        Merck, Darmstadt/Germany 
Forskolin       Sigma, Taufkirchen /Germany 
Glutamine solution       Gibco, Paisley/UK 
Glutaraldehyde      Sigma, Taufkirchen /Germany 
Glycine        Sigma, Taufkirchen /Germany 
HCl (1 N solution) Roth, Karlsruhe/Germany 
HEPES  ICN Biomedicals, Aurora (OH)/USA 
Hoechst 33342 (bisBenzimide)    Sigma, Taufkirchen /Germany 
IBMX        Sigma, Taufkirchen /Germany 
K3Fe(CN)6        Roth, Karlsruhe/Germany 
KCl         Sigma, Taufkirchen /Germany 
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Item        Provider 
L - Ascorbic acid       Sigma, Taufkirchen /Germany 
L-Glutamic acid       Sigma, Taufkirchen /Germany 
Lead(II) acetate trihydrate (Pb-ac) Sigma, Taufkirchen /Germany 
LiCl Sigma, Taufkirchen /Germany 
MAM (Methylazoxy methanole acetate) NCI, Kansas City/Missouri 
Matrigel  Becton dickinson, Franklin Lakes 
(NJ)/USA 
MeHgCl (Methylmercury (II) chloride)   Sigma, Taufkirchen /Germany 
Methanole        Roth, Karlsruhe/Germany 
MgCl2         Fluka, Buchs/Switzerland 
MK-801 (Dizocilpine)      Sigma, Taufkirchen /Germany 
Na2EDTA        Sigma, Taufkirchen /Germany 
NaCl         Sigma, Taufkirchen /Germany 
NADPH        Sigma, Taufkirchen /Germany 
NaH2PO4       Merck, Darmstadt/Germany 
NaN3        Sigma, Taufkirchen /Germany 
NaOH        Merck, Darmstadt/Germany 
NMDA (N-methyl-d-aspartic acid)     Sigma, Taufkirchen /Germany 
Normal horse, rabbit and goat sera     Vector, Burlingame (CA)/USA 
NT2 precursor cells  Stratagene Corp., La Jolla (CA)/USA 
Penicilline / streptomycine solution     Gibco, Paisley/UK 
Petri dishes (bacteriological culture grade)    Greiner, Hamburg/Germany 
PFA         Sigma, Taufkirchen /Germany 
PMA        Alomone Labs, Jerusalem/Israel 
Poly-d-lysine (PDL)      Sigma, Taufkirchen /Germany 
Retinoic Acid (RA)       Sigma, Taufkirchen /Germany 
Secondary biotinylated antibodies     Vector, Burlingame (CA)/USA 
SMBS  (Sodium metabisulphite)    Sigma, Taufkirchen /Germany 
Sodium borohydride      Sigma, Taufkirchen /Germany 
Sodium dithionite (Na2S2O3)     Merck, Darmstadt/Germany 
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Item        Provider 
D(+)-Sucrose       Sigma, Taufkirchen /Germany 
Tissue-Tek Sakura Finetek, 
Zoeterwoude/Netherlands 
TRIS         Sigma, Taufkirchen /Germany 
Triton X100        Sigma, Taufkirchen /Germany 
Trypsine EDTA solution (1x)     Gibco, Paisley/UK 
VPA (Valproic acid sodium salt)    Sigma, Taufkirchen /Germany 
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3. Results 
3.1 Characterisation of NT2 neuronal cells 
3.1.1 Neuronal differentiation 
NT2 precursor cells were initially kept in adherent culture until 90 % confluency (Fig. 4a) 
and then differentiated according to the method of Paquet-Durand et al. (2003). When NT2 
cells were seeded in the presence of retinoic acid onto non-adhesive bacteriological grade 
petri dishes, they formed free floating spheres which support cellular proliferation and neural 
differentiation (Fig. 4b). After replating to adherent substrate some of the cells which 
migrated out of the spheres showed already long processes, typical for neuronal morphology 
(Fig. 4c). During cell culture in medium containing mitotic inhibitors (Fig. 4d) the 
preferential adhesion of differentiating neurons to each other became apparent. After the 
inhibitor treatment and selective trypsinisation, purified neurons were cultured for at least 10 
days on matrigel coated cover slips prior to immunocytochemical characterization. During 
this period, the initially dispersed NT2 neurons formed clusters and extended numerous long 
neurites (Fig. 4e). As reported by Pleasure et al. (1992), cell cultures contained more than 
95% postmitotic neurons, less than 5% large (~100-300 µm) undifferentiated, but postmitotic 
epitheloid cells, and no proliferating precursor cells. 
 
Fig. 4 Differentiation of Ntera-2 (NT2) precursors into neurons. a Stock of undifferentiated 
precursor cells, grown on an adherent substrate. b Day 8: neurospheres after 1 week of 
differentiation in the presence of 10 µM retinoic acid in a non-adherent Petri dish. c Day 17: 
mixed culture of NT2 neurons and NT2 precursors after being replated. d Day 22: culture of 
NT2 neurons in inhibitor medium, with few precursor cells remaining. e Day 41: purified 
neurons, 14 days after final replating on PDL and matrigel. Bars 100 µm (a–d), 50 µm (e) 
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3.1.2 Neuronal phenotype 
To confirm neuronal differentiation in the aggregate culture the expression of cytoskeletal 
markers both for immature precursors and mature neurons were tested. NT2 precursor cells 
did not express type III ß-tubulin (Fig. 5a). They expressed the intermediate filaments nestin 
and vimentin (Fig. 5b, c) which are typical for neuronal precursor cells (Chu et al. 2006). 
NT2 neurons displayed immunoreactivity to type III ß-tubulin, MAP-2 and tau (Fig. 5d, g, h). 
Tau staining was weak in cultures stained eight days after replate, but became much stronger 
after prolonged outgrowth and maturation of the cell culture. Fig. 5h displays tau staining 
after 24 days in culture. The few large epitheloid cells that accompany NT2 neurons displayed 
only faint staining for type III ß-tubulin, and no immunoreactivity to antibodies against MAP-
2 and tau (arrowheads in Fig. 5d, g, h). Instead, these cells retained cytoskeletal proteins 
characteristic for the precursor stadium such as the intermediate filaments vimentin and nestin 
(Fig. 5e, f) which were not expressed by neurons (arrowheads in Fig. 5e, f). They differed 
from the proliferating precursors, however, by their large size (diameter 100-300 µm as 
compared to precursors: 20-30 µm), and by the fact that they did not divide. 
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Fig. 5 Cytoskeletal elements (red) and corresponding DAPI-labeled nuclei (blue) in NT2 
precursor cells (a–c) at 24 h after seeding onto plastic and in purified NT2 neurons (d–i) 
cultured for 10 days on matrigel before fixation (except for h: 24 days). a NT2 precursor cells 
express only minimal amounts of β-tubulin type III. b Precursors express nestin. c Precursors 
express vimentin. d All neuronal cells display immunoreactivity for β-tubulin type III, whereas 
non-neuronal epitheloid cells (arrowheads) do not. e Nestin is expressed only by nonneuronal 
epitheloid cells, but not by neurons (arrowheads). f Vimentin is expressed only by non-
neuronal epitheloid cells, but not by neurons (arrowheads). g MAP-2 is expressed by neurons, 
but not by non-neuronal epithelial cells (arrowheads). h Processes (but not perikarya) of 
neurons express tau, whereas non-neuronal epitheloid cells (arrowhead) do not. i Multiple 
growth cones (arrowheads) on NT2 neurons, at 24 h in culture, labeled with green-
fluorescent phalloidin; the red staining is β-tubulin type III. Bar 100 µm (a, b, d–h), 50 µm (c, 
i) 
Within ten days of culture, NT2 neurons aggregated into clusters and formed multiple neurites 
with numerous contacts (Fig. 5d, g, h). To test whether some of these contacts might contain 
functional connections, a staining for synapsin, a soluble protein associated with the reserve 
pool of synaptic vesicles, was performed. A strong staining for synapsin (Fig. 6a, d) 
  21 
predominantly in the neural processes was found. The staining appeared punctate, indicating 
local areas of high concentrations of the synaptic marker, as would be expected in presynaptic 
structures. From one week cultured neurons to two week cultured neurons the number of 
synaptic punctae (s.p.) increased. By generating an optical mask beyond a certain intensity 
threshold, the quantification of these synaptic punctae (Fig. 6c, f) revealed 37± 2.3 s.p./100 
cells in one week and 67± 4.6 s.p./ 100 cells in two week cultured neurons. 
 
Fig. 6 NT2 neurons stain for synapsin (inverted immunofluorescence staining) after 1 week 
(a) and after 2 weeks (d) culture; DAPI nuclear counterstaining (b, e). On the basis of the 
generated mask to remove the background staining (c, f, not inverted) the increase of synaptic 
punctae becomes apparent. Bar 50 µm 
3.1.3 Neurotransmitters 
NT2 neuron cultures contained a strong immunostaining against GABA (Fig. 7a) in 14.5 ± 
2.3 % of the neurons, that was above a weak background staining which also appeared in the 
non-neuronal epitheloid cells. 
A large population of neurons were immunopositive for the cholinergic marker choline 
acetyl-transferase (ChAT, Fig. 7c). This marker was detected in the soma and processes; cell 
counting revealed 34.0 ± 6.7 % ChAT-positive neurons. 
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Fig. 7 Inverted immunofluorescence images of NT2-neurons stained for the neurotransmitters 
GABA (a) and acetylcholine (c) and the corresponding DAPI labeled nuclei (b, d). a A subset 
of NT2-neurons is strongly immunoreactive for GABA; c A large population of neurons are 
immunopositive for the cholinergic marker choline acetyl transferase. Bars 50µm 
 
Previous reports showed differentiation into dopaminergic NT2 neurons by exposure either to 
lithium (Zigova et al. 1999, 2000) or to a mix of growth factors, dopamine, and high 
intracellular cAMP levels by the application of forskolin and IBMX (Iacovitti et al. 2001). In 
each case, with or without these treatments, no indicators of a dopaminergic phenotype could 
be observed. Two different primary antibodies against tyrosine hydroxylase, antityrosine 
hydroxylase MAB318 (Fig. 8a) and anti-tyrosine hydroxylase AB152 (Fig. 8c) were used. 
Both of which stained appropriate control tissue (mouse brain slice, see inset in Fig. 8a; 
human tissue microarray, see inset in Fig. 8c). Anti-dopamine immunostaining was absent 
(Fig. 8e) unless the cells were preincubated for 15 min in 1 mM dopamine prior to fixation 
(see inset in Fig. 8e). This confirmed the reliability of the staining procedure. 
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Fig. 8 Inverted immunofluorescence images of NT2 neurons cells stained for tyrosine 
hydroxylase and dopamine; DAPI was used as a nuclear counterstain (b, d, f). Several 
primary antibodies were used all of which delivered negative results. a Anti-tyrosine 
hydroxylase MAB318. c Anti-tyrosine hydroxylase AB152. e Anti-dopamine AHP847. Insets: 
Positive controls, mouse brain slice (a), human brain tissue microarray (c), and NT2 neurons 
pretreated with 1 mM dopamine for 15 min before fixation (e). Bars 50 µm 
  24 
3.2 Anoxia in NT2 neuronal cell cultures 
3.2.1. Response of NT2 neuronal cultures to anoxic conditions 
Exposure to anoxic conditions caused neuronal damage and cell death in differentiated NT2 
neuron cultures as assessed by the decrease in their viabilities. The main loss in neuronal cells 
occurred either during anoxia or in the first 24 h after anoxia. Only a small amount of cell 
death occurred between 24 h and 72 h post anoxia (Fig. 9a). For this reason and for the sake 
of clarity, only the data from the 48 h post anoxia time point are shown in the following 
figures. The extent of damage was dependent on the duration of anoxia, with an anoxia of 
3.30 h showing the strongest loss of viability (dark bars in Fig. 9b, c). Both anoxia with and 
without the addition of glutamate reduced the viability of the neuronal cultures. The decline in 
viability was, however, far more pronounced when glutamate was added to the medium (Fig. 
9).  
3.2.2. Neuroprotective effect of diltiazem on NT2 neuronal cultures 
It has been reported that MK801, a commonly used NMDA channel blocker, protects NT2 
neurons in the model of simulated ischemia against glutamate-induced damage (Paquet-
Durand and Bicker, 2004). In this study, the neuroprotective capacities of diltiazem and 
MK801 after an in vitro simulation of ischemia were compared. Like MK801, diltiazem was 
able to reduce the excitotoxic effect of glutamate on viability of NT2 neuronal cell cultures. In 
experiments with durations of anoxia ranging from 2.15 h to 3.30 h, the damage caused by the 
addition of glutamate was reduced by both drugs to the level of samples that were not exposed 
to glutamate. However, the diltiazem concentrations necessary to achieve this effect were 
considerably lower than MK801 concentrations (Fig. 9b). Both MK801 and diltiazem were 
unable to reduce the percentage of cell death caused by the anoxic treatment alone. At a 
concentration of 10 µM, diltiazem already exhibited a significant protection of NT2 neuronal 
cultures from excitotoxic injury. The optimal levels of neuroprotection were seen at 10 and 
100 µM (Fig. 9b). At 250 µM, diltiazem did not increase the viability of NT2 neuronal cell 
cultures any further. Whereas diltiazem was effective under conditions simulating ischemia, it 
showed no significant neuroprotective action against anoxia without glutamate in the medium. 
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3.2.3. Neuroprotective effect of diltiazem on mouse primary cortical neuronal 
cultures 
To confirm the protective effect of diltiazem in a primary culture system, additional 
experiments were performed using cortical neuron cultures obtained from neonatal mice. The 
impact of simulated ischemia on the viability of the murine cultures was less pronounced than 
in the NT2 neuronal cultures. While the NT2 neuronal cultures lost approximately 70 % of 
their original viabilities after 3.30 h of anoxia, the murine cultures lost only about 40 % of 
their viabilities in the same period (Fig. 9b, c). However, at a concentration of 100 µM, 
diltiazem also demonstrated a significant neuroprotective effect for all three durations of 
anoxia. The use of 250 µM diltiazem led to a slight reduction of the viability when compared 
to the 100 µM diltiazem values or the samples without glutamate, pointing towards a possible 
adverse effect of diltiazem at higher doses (Fig. 9c). 
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Fig. 9 Protective effects of diltiazem and MK801 on viabilities of NT2 neuronal cell cultures 
and mouse primary cortical neuron cultures. (A) NT2 neurons were cultured for 28 days in 
vitro (DIV) and then exposed to 2.45 h of anoxia and 500 µM glutamate/glycine (Glu). The 
time course of viability in the cell cultures was followed during 72 h post anoxia. (B) 
Comparison of the neuroprotective effects of diltiazem (Dil) and MK801 (MK) 48 h after 
anoxia. After 20 DIV, the NT2 neurons were subjected to differing lengths of anoxia (2.15 h, 
2.45 h, 3.30 h). Samples treated with glutamate and diltiazem or MK801 are compared to 
samples that were treated with glutamate only. Diltiazem was added to the samples in 
concentrations ranging from 5–250 µM. At 10 µM, diltiazem compensates the glutamate-
induced neuronal damage achieving a similar level of protection as 250 µM MK801. The bars 
show mean values with n=3–7 independent experiments with 5–6 individual measurements in 
each. (C) Comparison of the neuroprotective effect of different concentrations of diltiazem 48 
h after anoxia on mouse primary cortical neuron cultures. After 5 DIV, the neuronal cultures 
were subjected to differing lengths of anoxia (2.15 h, 2.45 h, 3.30 h). The effect of anoxia on 
the viability of the primary neuron cultures was less pronounced when compared with NT2 
neuron cultures. Still, at 100 µM, diltiazem completely protected the primary neurons against 
glutamate-induced damage. The bars show mean values taken fromn=2–3 independent 
experiments with 6 individual measurements in each. Levels of significance (B, C) were 
calculated by comparing Dil+Glu values with the corresponding Anoxia+Glu value (i.e. the 
second group of columns in the histogram from the left); error bars represent SEM; 
significance levels are: *p <0.05; **p <0.01; ns=not significant. 
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3.3 Migration of NT2 neurospheres 
3.3.1 Observation of migration 
When one-week retinoic acid treated NT2 neurospheres were seeded on an adherent surface 
cells started to migrate out of these spheres. To visualize how cells migrate out, the cells were 
observed under a Zeiss Axiovert 200 light microscope and time lapse video microscopy were 
performed. The cells do not migrate in the observation chamber, when time lapse video 
microscopy were started one hour after seeding. For that reason, the cells were incubated for 
24 h at 37 °C and 5 % CO2 before starting the observation. The resulting time lapse video 
visualized the migration process in an impressive way. The picture sequence taken at 4 hours 
time interval of Fig. 10 provides a representation of the migration process. 
 
Fig. 10 Migration of NT2 neurospheres after 24, 28, 32, 36, 40 and 44 hours. Bars 100 µm 
 
In a further experiment, the migration of NT2 neurospheres was observed over one week and 
every day up to every third day a picture were taken and analysed. The cells migrated at 
constant speed. These demonstrated that this cell migration is a linear process without any 
slow down of motility (Fig. 11). 
 
  29 
time [days]
0 2 4 6 8
m
ig
ra
tio
n
 
[m
m
]
-0,2
0,0
0,2
0,4
0,6
0,8
 
Fig. 11 Migration of NT2 cells over a period of one week demonstrate the linear process of 
the cell migration. 
3.3.2 Immunocytochemical characterisation of migrating NT2 neurospheres 
To characterise the NT2 neurospheres and the migrating cells after 24 and 48 hours migration 
several immunocytochemical stainings of cytoskeletal markers were performed. For 24 h 
migrated neurospheres show similar results as 48 h migrated cells. The intermediate filament 
nestin which is typical for neuronal precursor cells is expressed in the neurosphere as well as 
in the migrating cells (Fig. 12a). Type III ß-tubulin, which is a marker for neuronal cells is 
expressed in only a few cells and is located in the neurosphere (Fig. 12b). A staining with 
phalloidin visualised the actin cytoskeletal structure of the neurosphere and the migrating 
cells (Fig. 12c). 
 
Fig. 12 Immunocytochemical labelling of cytoskeletal markers (red) and corresponding 
DAPI-labeled nuclei (blue) of 24 h migrated NT2 neurospheres. a Nestin is expressed in the 
neurosphere as well as in the migrating cells, b Type III ß-tubulin is expressed in only a few 
cells and is located in the neurosphere and c phalloidin visualised the actin cytoskeletal 
structure. Bars 100 µm 
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For the detection of cell proliferation, cells were exposed to BrdU for 2 hours and labelled for 
incorporated BrdU with an anti-BrdU antibody (Fig. 13). BrdU was incorporated into 24.2 ± 
2.4 % cells after 24 h migration and into 14.8 ± 0.7 % after 48 h migration (n=4 spheres 
counted). This decrease of cell proliferation after a longer migration period is probably caused 
by application of retinoic acid which is a known inhibiter of cell proliferation (Kikuchi et al., 
1984). 
 
 
Fig. 13 Cell proliferation of NT2 neurospheres. Cells labelled for incorporated BrdU (red), 
nuclear counterstaining (DAPI) appears blue. After 24 h migration (a) 24.2 ± 2.4 % cells 
were labelled and after 48 h migration (b) 14.8 ± 0.7 %. Bars 100 µm 
 
3.3.3 Migration assays in present of test compounds 
To investigate the effects of several test compounds on migration of NT2 neurospheres a 
principle of evaluation has been established according to the method described in Moors et al. 
(2007) (Fig. 14). After 24 h and 48 h migration the distance between the edge of the sphere 
and the furthest migrated cells have been measured in treated and untreated cells at four 
distinct positions per neurosphere (n=32 distances per sample were measured). Dose/effect-
profiles and resultant EC50 values (= compound concentration with 50 % effect) in relation to 
the untreated positiv control were calculated and compared with acute toxicity values 
determined by an Alamar Blue ® viability assay. Each experiment was performed two or 
three times. 
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Fig. 14 Principle of evaluation illustrated on untreated migrating NT2 neurospheres. The 
distance (red arrows) between the edge of the sphere (red circle) and the furthest migrated 
cells were measured after a 24 h and b 48 h migration at four distinct position per 
neurosphere. Bars 100 µm 
 
In some cases problems with this evaluation method occurred. The migration of cells was 
disturbed when the matrigel coating was inhomogeneous (Fig. 15a). When neurospheres were 
to small and no edge was visible (Fig. 15b) or when too many spheres were seeded (Fig. 15c), 
it was not possible to evaluate these spheres. 
 
Fig. 15 Problems of evaluation: a Inhomogeneous Matrigel coating, b no edge in the sphere 
and c too many cells. Bars 100 µm 
 
To establish this migration assay, two compounds with known effects on neuronal migration 
were tested. On the one hand ethanole (EtOH) was tested which is a known developmental 
neurotoxic agent as seen in the fetal alcohol syndrome (Guerri, 1998). On the other hand, I 
used Phorbol-12-myristate-13-acetate (PMA) which is an activator of protein kinase C (PKC) 
signaling (Isakov et al., 1985) and stimulates migration of neural cells in vivo (Sears and 
Ciment, 1988) and in vitro (Moors et al., 2007). After exposure to 2 % EtOH the migration 
out of NT2 neurospheres was decreased to 59 ± 3.2% after 24 h and to 34.9±1.9 % after 48 h 
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when compared to untreated controls. In contrast, exposure to 10 nM PMA resulted in a 
stimulation of migration to 302 ± 10.6 % of the controls after 24 h and to 251.6 ± 10.1 % after 
48 h (Fig. 16a, b). These changes in cell migration differ from acute viability values (Fig. 
16c, d). EC50 values calculated for the inhibition via Ethanol demonstrated the difference 
between the migration and cytotoxicity effect (Table 2) and that changes in migration are not 
caused by changes in viability. These results obtained in the migration assays indicate that the 
selected chemicals impair neural migration in vitro. 
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Fig. 16 a EtOH [2 %] treated and b PMA [10 nM] treated NT2 neurospheres after 24 h 
migration. With EtOH treatment there is a clear decrease of migration and with PMA 
treatment a clear increase of migration becomes visible. Bars 100 µm. Migration (circles) 
and viability values (triangles) of c EtOH treated and d PMA treated NT-2 neurospheres after 
24 h (black) and 48 h (red) migration validate this effect. The changes in cell migration differ 
from acute viability values. Data taken from one typical experiment, mean values for n=32 
measurements, error bars indicate ± SEM. 
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EtOH [%] EC50 Migration 
EC50 
Viability Difference 
24 h 1.3 ± 0.7 5.1 ± 0.7 yes 
48 h 1.0 ± 0.5 4.2 ± 0.5 yes 
Table 2 EC50 values calculated for migration and viability of the inhibition via Ethanol 
demonstrated the difference between the migration and cytotoxicity effect. Each value 
represents the mean ± SEM of two or three separate experiments 
In the context of the BMBF (Federal Ministry for Education and Research) project: 
„Development of predictive in vitro tests as replacement of animal experiments for testing 
developmentally specific neurotoxicity“ potential developmental neurotoxic compounds 
[methylazoxy methanol acetate (MAM), methyl mercury (MeHgCl), valproic acid (VPA), 
lead-acetate (Pb-ac)] and non developmental neurotoxic compounds [glutamate and 
acetaminophen] (Table 3) were analyzed in the neurosphere migration assays. The potential 
developmental neurotoxic compounds all have known neurotoxic properties. MeHgCl is a 
compound which disturbs cell migration in vivo (Castoldi et al., 2001; Clarkson, 2002) as well 
as MAM, which also inhibits neuronal migration in vivo (Baraban and Schwartzkroin, 1995; 
Colacitti et al., 1998). Pb is a potent neurotoxic agent, especially during nervous system 
development (White, 2007). The anti-epileptic drug VPA acts as tumor suppressor in vivo and 
in vitro, but also as teratogen causing various malformations including neural tube defects 
(Gotfryd et al., 2007) and inhibits neural cell motility in vitro (Fuller et al., 2002). The 
neurotransmitter glutamate and the analgesic drug acetaminophen, also known as 
paracetamol, supposedly do not have any developmental neurotoxic properties and serve as 
negative controls. 
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Table 3 BMBF project test substances for A developmental neurotoxicity and for B 
cytotoxicicity, but not developmental neurotoxicity. 
 
The results of the migration assays performed with the BMBF project test substances indicate 
that methyl mercury is the most toxic compound and glutamate the fewest toxic (Fig. 17). The 
24 h and 48 h results of migrated, treated NT2 neurospheres show different effects. The EC50 
values for migration differ from viability after 24 h for the test substances VPA, MAM and 
methyl mercury, whereas EC50 values for the non developmental neurotoxin glutamate but 
also for lead-acetate did not differ from acute toxicity values (Table 4). In contrast after 48 h 
the developmental neurotoxin lead-acetate inhibited specifically migration, whereas for the 
non developmental neurotoxin glutamate but also for VPA, MAM and methyl mercury did 
not. These results indicate that it is important to measure at several timepoints to see all 
effects on migration. The EC50 values for acetaminophen could not be determined (N.D.) 
because it was not possible to solve adequate high concentrations. 
 
Substance CAS-No. Provider Catalog-No. Lot-No. Solvent 
MAM 
(Methylazoxy 
methanole 
acetate) 
592-62-1 NCI 
NCI 
#F0040, 
MRI #213 
ET-11-
109- 
1 Batch 3 
PBS 
MeHgCl 
(Methylmercury 
(II) chloride) 
115-09-3 Sigma 442534 08409KH PBS 
VPA (Valproic 
acid sodium 
salt)  
1069-66-5 Sigma P4543 036K0731 Medium 
Lead(II) acetate 
trihydrate (Pb-
ac) 
6080-56-4 Sigma 467863 07523HD H2O dest. 
Substance CAS-No. Provider Catalog-No. Lot-No. Solvent 
L-Glutamic 
acid 142-47-2 Sigma G1626 096K0111 Medium 
Acetaminophen 103-90-2 Sigma A5000 096K0072 DMSO 
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Fig. 17 Migration (circles) and viability values (triangles) of the tested BMBF compounds 
after 24 h and 48 h migration. After 24 h migration values differ from viability values for the 
test substances VPA, MAM and methyl mercury; after 48 h lead-acetate inhibited specifically 
migration. Data taken from one typical experiment, mean values for n=32 measurements, 
error bars indicate ± SEM. 
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Table 4 EC50 values calculated for migration and viability for the tested BMBF compounds 
after 24 h and 48 h migration. The values demonstrated the difference between migration and 
viability and the associated developmental neurotoxic effect of these test compounds. The 
EC50 values for acetaminophen were not determinable (N.D.) Each value represents the mean 
± SEM of two or three separate experiments 
 
In migration assays with VPA treatment the cells show a modified cellular geometry (Fig. 
18a). The ratio between length and width of migrated cells increased by treatment with VPA. 
This effect is highly significant (*** = p<0.001) for 5mM VPA treated cells after 48 h 
migration (Fig. 18b). Such an effect did not appear with any other treatment and seems to be 
characteristic for VPA treatment. 
 
 
 
 
 
 
Substance EC50 Migration EC50 Viability Difference 
VPA [mM] 15.8 ± 2.2 91.6 ± 28.3 yes 
MAM [µM] 291.8 ± 83.5 1038.2 ± 226.6 yes 
MeHgCl [µM] 4.7 ± 0.5 9.6 ± 1.7 yes 
Pb-ac [mM] 2.3 ± 0.1 2.6 ± 0.2 no 
Glutamate [mM] 129.7 ± 9.3 182.5 ± 14.6 no 
Acetaminophen  N.D. N.D.   
Substance EC50 Migration EC50 Viability Difference 
VPA [mM] 11.0 ± 2.9 11.4 ± 7.0 no 
MAM [µM] 180.5 ± 36.6 208,8 ± 58,7 no 
MeHgCl [µM] 4.0 ± 0.3 4.1 ± 0.5 no 
Pb-ac [mM] 0.6 ± 0.1 2.1 ± 0.4 yes 
Glutamate [mM] 126.3 ± 6.6 143.8 ± 11.4 no 
Acetaminophen  N.D. N.D.   
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Fig. 18 Cellular geometry of VPA treated cells after 48 h migration. a Migrated, 5mM VPA 
treated, cells show a changed cellular geometry. Bar 50 µm. b The ratio between length and 
width of migrated cells increased by treatment with VPA. This effect is highly significant (*** 
= p<0.001) for 5mM VPA treated cells, mean values for n=40, error bars indicate ± SEM. 
  38 
4. Discussion 
4.1 NT2 neurons: Neuronal phenotype, synaptic marker and 
neurotransmitters 
Morphological analysis and staining for the major cytoskeletal markers have confirmed that 
the improved differentiation protocol (Paquet-Durand et al., 2003) results in the development 
of differentiated human neurons within less than 1 month. The cultures contain pure neurons 
with less than 5 % contamination by undifferentiated, but postmitotic, cells. In one week and 
two week cultured neurons a punctate staining for the presynaptic marker synapsin could be 
observed. The number of synaptic punctae increased over time. Whether these sites of local 
concentration of synaptic vesicle- associated protein represent functional synapses remains to 
be analyzed. On the postsynaptic side, there is evidence for functional NMDA receptors in 
NT2 neurons as derived both from the standard differentiation protocol (Sandhu et al., 2003) 
and from the protocol involving floating spheres (Paquet-Durand and Bicker, 2004). 
Podrygajlo et al. (2010) detected spontaneous postsynaptic currents in human NT2 neurons 
differentiated in aggregate culture using the outside-out patch-clamp configuration. Moreover 
it has been shown that these human model neurons display synaptic vesicle recycling 
(Tegenge et al., 2009). 
Conventionally generated NT2 neurons have been shown to display a broad variety of 
neurotransmitter phenotypes (Guillemain et al., 2000), including cholinergic, GABAergic, 
catecholaminergic, serotonergic, and peptidergic phenotypes. The percentage of cholinergic 
neurons generated under the rapid differentiation protocol (35 %) is in the same range as that 
reported for the adherent culture differentiation protocol (47 %, Guillemain et al., 2000). In 
contrast the observed number of GABAergic neurons is much lower (only 15 %), as opposed 
to 62 % (Guillemain et al., 2000). For the dopaminergic phenotype, the difference is even 
more striking, since I was unable to observe any markers for a dopaminergic phenotype, 
compared with 50 % TH positive cells observed by Guillemain et al. (2000). Even all attempts 
to induce this phenotype via lithium application (Zigova et al., 1999, 2000) or the application 
of a mix of FGF1 and various co-activators (Iacovitti et al., 2001) were not successful. At 
present, it is unclear whether these variations in the number of GABAergic and dopaminergic 
cells are attributable to differences in the neuronal differentiation protocol alone, or whether 
other factors, e.g., media composition, passage number of precursors, or their genetic 
instability, also play a role here. 
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The NT2 neurons develop in the presence of high concentrations of RA, which is known to 
induce caudal positional identity in developing nervous tissue (Maden, 2002). This 
caudalizing effect of RA alone might be sufficient to induce a high number of cholinergic 
neurons from NT2 precursors. Thus, NT2 neurons might provide a promising tool for 
transplantation based therapeutical strategies in motor neuron diseases such as ALS, where 
they have been successfully used in animal models (Garbuzova-Davis et al., 2002; Saporta et 
al., 2002). 
 
4.2 NT2 neurons in a model of simulated ischemia 
Screening for neuroprotective substances in vivo involves mainly rodent (Li et al., 1999; 
Colbourne et al., 1999) or pig (Foster et al., 2001) animal models. Similarly, the cell culture 
systems established to simulate ischemic conditions in vitro, are also largely based on primary 
neuronal cells and slice preparations obtained from rodents (Bartmann-Lindholm and Carter, 
1999; Campbell et al., 2000; Melzian et al., 1999; Schurr et al., 1995a,b). Since there are 
considerable differences in the response to neuroprotective substances between different 
species (reviewed in Munir et al., 1995), human nerve cells are especially desirable in 
screening assays for protective drugs. NT2 neurons integrate, survive and promote functional 
recovery in rodent brains (Kleppner et al., 1995; Borlongan et al., 2000; Watson et al., 2003). 
Their successful transplantation into human stroke patients (Kondziolka et al., 2001) shows 
that NT2 neurons are indeed very similar to primary neurons, underlining their value for the 
screening of drugs that are intended for human use. Consequently, in vitro systems of 
ischemic human NT2 neurons have been used to evaluate the protective effects of glutamate 
receptor blockers (Rootwelt et al., 1998), barbiturates (Almaas et al., 2000) and of Coenzyme 
Q10 (Sandhu et al., 2003). The application of simple technical equipment for the simulation 
of hypoxic/ischemic conditions in postmitotic NT2 neurons (Paquet-Durand and Bicker, 
2004) further improved the usefulness of these human neurons for basic research in the 
pathophysiology of ischemic injury. Excitotoxicity caused by an over stimulation with the 
neurotransmitter glutamate is thought to be a major factor of neuronal cell damage in the 
pathology of cerebral stroke (Olney, 1974; Kristián and Siesjö, 1998). Even though the 
cellular mechanisms accounting for glutamate excitotoxicity are not well understood, a major 
cause seems to be the excessive cellular influx of Ca2+. Using Ca2+ imaging, Gao et al. (1998) 
have shown that NT2 neurons exhibit transient fluctuations of intracellular Ca2+ 
concentrations. These spontaneous Ca2+ transients were also observed in the NT2 culture 
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system and are due to an influx of extracellular Ca2+, since they do not occur in Ca2+ free 
saline (Paquet-Durand and Bicker, 2004). Moreover, the NT2 neurons generated by the rapid 
cell differentiation protocol show NMDA- and glutamate- stimulated Ca2+ influx, offering the 
possibility to investigate excitotoxic cell death. The functional expression of NMDA-type 
glutamate receptors and the vulnerability to anoxic insult provide further confirmation for the 
neuronal status of rapidly differentiated NT2 cultures. Unfortunately, NMDA receptor 
antagonists that appear to be neuroprotective in vitro and in animal models, have so far failed 
in human clinical trials (Hoyte et al., 2004a). Combined with anoxia, glutamate application 
reduced cellular viability in the NT2 cultures effectively, thus mimicking ischemic neuronal 
damage. The main loss in viability seemed to occur during the first 24 h after anoxia. This 
effect of glutamate on viability could be prevented by the addition of relatively high 
concentrations of MK-801, a commonly used NMDA-channel blocker (McDonald et al., 
1987). In models of relatively mild hypoxia/hypoglycemia (Rootwelt et al., 1998; Almaas et 
al., 2000; Sandhu et al., 2003), 10 µM MK801 was found to completely protect NT2 neurons 
from glutamate- induced cell damage. In the NT2 model of strong anoxia (Paquet-Durand and 
Bicker, 2004) and in a model of NMDAinduced excitotoxicity (Lockhart et al., 2002), 
however, concentrations of at least 100 µM MK-801 were needed to effectively protect NT2 
neurons. In this work, optimal neuroprotection was achieved with MK801 concentrations of 
250 µM and above. Here, it has been shown that far lower concentrations of diltiazem 
completely protected the NT2 neurons against glutamate-induced cell damage in the model of 
simulated ischemia (10 µM diltiazem versus 250 µM MK-801). The additional experiments 
performed using cortical neuron cultures obtained from neonatal mice were able to confirm 
the protective effect of diltiazem in a primary culture system. However, the effect of 
simulated ischemia on the viability of the murine cultures was less pronounced than in the 
NT2 neuronal cultures. 
D-cisdiltiazem is an L-type voltage gated calcium channel blocker that was introduced as a 
drug for human use in the 1970s. Since then, ample experience has been acquired concerning 
the treatment of human heart arrhythmias, high blood pressure and angina pectoris with 
diltiazem (Chaffman and Brogden, 1985; Weir, 1995; O'Connor et al., 1999). Ono et al. 
(1991) demonstrated that diltiazem had a positive effect on neurologic recovery score after 
global brain ischemia in dogs. Diltiazem was also able to partly rescue rod photoreceptor cells 
in a mouse model of retinal degeneration (Frasson et al., 1999, Vallazza-Deschamps et al., 
2005). Furthermore, diltiazem and MK-801 have been shown to decrease neuronal damage in 
in vitro and in vivo rat models of cerebral ischemia (Schurr et al., 1995a,b; Li et al., 1999). 
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Using electrophysiological investigations, Schurr et al. (1995a,b) could show that both 
diltiazem and MK-801 are able to protect hippocampal slices against hypoxic damage alone. 
In the NT2 cell culture model, diltiazem did not protect neurons after anoxia treatment 
without added glutamate. However, a direct comparison of the anoxic period, lasting for more 
than 2 h in dissociated neuronal cell culture to the hypoxic conditions in tissue slices, lasting 
from 12 to 20 min (Schurr et al., 1995a,b) is rather difficult to draw. In extensive studies on 
the use of calcium antagonists for the treatment of hypertension (Hansson et al., 2000), the 
incidence of stroke in human patients treated with diltiazem was found to be relatively low, 
indicating that diltiazem might have an additional neuroprotective function (reviewed in 
Grossman and Messerli, 2004). To my knowledge, it has, however, not been tried on human 
neurons in ischemia related models. Moreover, I am not aware of any studies using diltiazem 
in the therapy of stroke patients. 
Interestingly, neither diltiazem nor MK-801 was able to completely protect neuronal cells 
since they were unable to restore viabilities beyond the level of cultures subjected to anoxia 
without glutamate. This implies that in the NT2 experimental system the viabilities of 
neuronal cultures are governed by both glutamate-dependent and independent forms of cell 
death. 
Based on its neuroprotective properties in the cultures of human model neurons the 
antihypertensive drug diltiazem, or structurally related compounds, are promising candidates 
for the treatment of ischemic brain injury during the acute phase of a stroke. Moreover, it will 
be essential to develop efficient strategies for delivering these compounds to the damaged 
brain tissue. 
 
4.3 NT2 neurospheres in migration assays 
The developing human brain is highly vulnerable to injury caused by neurotoxic compounds, 
much more than the adult brain. Only few industrial chemicals (lead, methylmercury, 
polychlorinated biphenyls [PCBs], arsenic and toluene) are proven to cause human brain 
injury by exposure to these chemicals during early fetal development (Grandjean and 
Landrigan, 2006). These few chemicals might be only the tip of the iceberg in consideration 
of the several thousands of known but untested chemicals (Fig. 19). About thousand of 
chemicals known to be toxic in experiments, only 200 chemicals are known to cause 
neurotoxic effects in adult human beings. According to the absence of systematic testing of 
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chemicals there is a great need to generate new approaches which are able to give clear 
evidences about the potential of chemicals to disturb human brain development. 
 
Fig. 19 Diagram of the extent of knowledge of neurotoxic chemicals. Of the thousands of 
known chemicals, only a small fraction have been proven to cause developmental 
neurotoxicity in humans. Figure from Grandjean and Landrigan (2006) 
 
For discovering potential developmental neurotoxic chemicals and the mechanism that control 
neuronal migration animal models have often been employed (Fishman and Hatten, 1993, 
Sass et al., 2001, Haase and Bicker, 2003). Neurosphere-based animal cultures have been 
used to study cell proliferation, differentiation and migration (Leone et al. 2005; Mizuno et al. 
2005). To replace animal models normal human neural progenitor (NHNP) cells (Moors et al., 
2007) or human NT2 cells (Hill et al., 2008) are a suitable alternative. Tegenge and Bicker 
(2009) showed that aggregates of human NT2 precursor cells are a useful tool to study 
regulatory mechanism of cell motility. According to this, the use of one-week 10 µM RA 
treated NT2 neurospheres show great promise to create a human model system for 
developmental neurotoxicity. Aggregated NT2 precursor cells started to migrate out after 
seeding on an adherent surface. The microscopic observation of the migration demonstrated 
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the linearity of this process and that no slow down of migration takes place over a period of 
one week after seeding. The proliferation of NT2 neurosphere cells decreased after a 
migration period of 48 hours caused by RA treatment which is a known inhibitor of cell 
proliferation (Kikuchi et al., 1984). Most of the cells in the neurosphere and the migrating 
cells were nestin-positive. Only a few cells in the neurosphere displayed type III ß-tubulin 
staining. This indicates that the migrating cells mainly consisted of neuronal precursor cells 
and that the NT2 aggregate culture system is a suitable human model for developmental 
neurotoxicity drug screening.  
To evaluate the distances the cells migrate relatively to a certain time intervall several images 
were acquired after 24 h and 48 h migration according to the method described in Moors et al. 
(2007). To obtain statistical reliability 32 distances for every sample were measured. In some 
early experiments, an inhomogeneous matrigel coating disturbed the migration. Therefore, the 
coating is a critical step for the successfully performed experiment. An alternative for 
matrigel coating would be using a laminin coating, which is also a known adhesive surface for 
neuronal cells (Pleasure et al. 1992). In this work, matrigel was preferred because of lower 
costs. The dose/effect-profiles and resultant EC50 values calculated from each drug treated 
migration experiment were compared with EC50 values of acute toxicity determined by an 
Alamar Blue ® viability assay to ensure whether migratory effects differ from toxic effects. 
Every experiment was repeated at least one or two times to intensify the results. The Alamar 
Blue ® viability assay was already established in the experiments of simulated ischaemia with 
NT2 neuronal cells. It has the advantage in comparison to commonly used tests (like MTT, 
Trypan blue and LDH) that cells survive the staining and can be monitored continuously. First 
migration assays were performed with exposure to model substances with known effects on 
migration like ethanole and PMA (Moors et al., 2007). The expected inhibitory effect of 
ethanole and the stimulatory effect of PMA on migration have been clearly verified after 24 h 
as well as after 48 h migration. The concentrations needed to obtain migratory effects differ 
from those of toxic effects and indicate that it is possible to impair neural migration in vitro in 
both directions - inhibitory and stimulatory. 
In the context of the BMBF project: „Development of predictive in vitro tests as replacement 
of animal experiments for testing developmentally specific neurotoxicity“ potential 
developmental neurotoxic compounds (MAM, MeHgCl, VPA and Pb-ac) and non 
developmental neurotoxic compounds (glutamate and acetaminophen) were analyzed by 
performing the established migration assays with NT2 neurospheres. MeHgCl is a compound 
which disturbs cell migration in vivo (Castoldi et al., 2001; Clarkson, 2002). This inhibitory 
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effect on migration could be confirmed by exposure NT2 neurospheres to MeHgCl. However, 
this effect on migration only differs after 24 h migration from the toxic effect in contrast to 
the 48h values that do not differ. The results of migration assays performed with MAM, 
which is also a known inhibiter of neuronal migration in vivo (Baraban and Schwartzkroin, 
1995; Colacitti et al., 1998), were similar to MeHgCl results. Only the 24 h migration values 
displayed a clear inhibition of migration which is not caused by toxicity. The anti-epileptic 
drug VPA is known as an tumor suppressor in vivo and in vitro, but also as teratogen causing 
various malformations including neural tube defects (Gotfryd et al., 2007) and inhibits neural 
cell motility in vitro (Fuller et al., 2002). In this work the inhibition of migration via VPA 
exposure of NT2 neurospheres was reflected after 24 h but not after 48 h. Interestingly, it was 
also observed that VPA treated cells displayed an altered morphology after migration. The 
ratio between length and width of migrated cells increased significantly in contrast to 
untreated cells. These changes in cellular geometry might accompany with a changed 
composition of the actin cytoskeleton properties by VPA exposure published by Walmod et 
al. (1998 and 1999). Also modifications of dendritic arborization in VPA treated motor cortex 
neurons are known (Snow et al., 2008). These findings indicate that VPA affects the cell 
motility by changing the cell morphology. The neurotoxic agent Pb, which affects especially 
during nervous system development (White, 2007), displayed a clear inhibition of migration 
out of NT2 neurospheres which is not caused by cytotoxicity. In contrast to the other tested 
compounds the migration were affected only after 48 h and not after 24 h. As expected for the 
neurotransmitter glutamate which is known to not have any developmental neurotoxic 
properties, there were no effects on migration of NT2 neurospheres detectable. The EC50 
values for the analgesic drug acetamniophen, which also to not have any developmental 
neurotoxic properties, could not be determined because it was not possible to solve adequate 
high concentrations. 
The different results of 24 h and 48 h migrated cells after drug treatment indicate that 
measuring at several timepoints is a critical step for a successfully performed experiment. 
Also the number of repetitions of every experiment is essential for statistical significance. 
Since the evaluation method is a rather time-consuming process, in future projects an 
automatical evaluation method for higher throughput would be useful. A first step in this 
direction would be to design software programs, which are able to automatically perform the 
image uptake or to automatically measure the distances of cell migration. 
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In summary, the results demonstrate that it is possible to perform with the human NT2 cell 
line in vitro tests for developmental neurotoxicity which are predictive for the effects of 
known and suspected developmental neurotoxins. 
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5. Publications 
 
Part of this thesis has been published in the following research articles: 
 
• Bicker, G., Gierse, A., Tan, S., Paquet-Durand, F. (2007): “Simulation of Stroke-
related Damage in Cultured Human Nerve Cells” ALTEX 24, Special Issue, 16-18 
 
• Paquet-Durand, F., Gierse, A., Bicker, G. (2006) „Diltiazem protects human NT-2 
neurons against excitotoxic damage in a model of simulated ischemia” Brain 
Research, 1124, 45–54 
 
• Podrygajlo, G., Tegenge, M.A., Gierse, A., Paquet-Durand, F., Tan, S., Bicker, 
G., Stern, M. (2009) “Cellular phenotypes of human model neurons (NT2) after 
differentiation in aggregate culture” Cell and Tissue Research 336, 439-452 
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